Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Macrophage colony-stimulating factor 1 receptor (CSF1R), also known as M-CSFR, CD115, or c-FMS, is a cell-surface transmembrane protein encoded by the CSF1R gene. It is a member of the type III protein tyrosine kinase receptor family and plays a central role in regulating the survival, proliferation, and differentiation of myeloid lineage cells, especially macrophages and microglia. Upon ligand binding (CSF-1 or IL34), the receptor dimerizes and activates downstream signaling pathways including PI3K/Akt, JNK, ERK/MAPK pathways. Mutations in CSF1R are linked to several diseases including ALSP, cancer, and skeletal disorders. Therapeutic targeting of CSF1R is under clinical investigation for various diseases.
Inhibition of CSF1R kinase activity; depletion or repolarization of tumor-promoting macrophages
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Macrophage colony-stimulating factor 1 receptor (CSF1R).